Logo

Partek Licenses Drug-Discovery Software to Leo Pharma

Dec 20, 2004

NEW YORK, Dec. 20 (GenomeWeb News) - Partek said today that it has licensed its AE Visualizer software to Leo Pharma of Denmark.

 

According to Partek, Leo will use the software, which was developed for the Elsevier MDL Assay Explorer data management system, to aid its drug discovery research.


Specific terms of the deal were not disclosed.

Breaking News
The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.